Forat Lutfi

6PUBLICATIONS

19CO-AUTHORS

Gene and molecular therapyCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 25, 2026

Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC.

|May 26, 2026

High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis.

|May 12, 2026

Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T Recipients.

|Mar 27, 2026

Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib-Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter Analysis.

Sruthi P Ramanan, Oyepeju F Abioye, Shebli Atrash

|Sep 09, 2021

The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.

Forat Lutfi, Noa G Holtzman, Ankit J Kansagra

|Nov 10, 2020

Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma.

Forat Lutfi, Noa Holtzman, Jonathan Siglin

Pageof 1

Frequent Collaborators

Ali Bukhari

Shebli Atrash

Prerna Mewawalla

Anita Mazloom

Omar Alkharabsheh

Zahra Mahmoudjafari

Al-Ola Abdallah

Jeries Kort

Anas Zayad

Gabriela Sanchez-Petitto

Frequent Collaborators

Ali Bukhari

Shebli Atrash

Prerna Mewawalla

Anita Mazloom